- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07671651
Effect of Ozone Therapy on Remineralization of Initial Caries Lesions in Children (OZONE-CARIES)
Effect of Ozone Therapy on the Remineralization of Initial Caries Lesions in Children: A Randomized Controlled Clinical Trial
Initial caries lesions can be managed using non-invasive treatment approaches that promote remineralization and prevent lesion progression. Ozone therapy has been suggested as an adjunctive treatment because of its antimicrobial properties and its potential to enhance remineralization.
This randomized controlled clinical trial aims to evaluate the effect of ozone therapy on the remineralization of initial caries lesions in children. Participants will be randomly assigned to receive either ozone therapy followed by application of a remineralizing gel or application of the remineralizing gel alone.
Changes in lesion status will be assessed over time using clinical and optical evaluation methods. The results of this study may contribute to the development of evidence-based minimally invasive approaches for the management of early caries lesions in pediatric patients.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Dental caries remains one of the most common chronic diseases affecting children worldwide. Initial non-cavitated caries lesions represent a reversible stage of the disease and provide an opportunity for non-invasive treatment through remineralization strategies.
Ozone therapy has attracted interest in pediatric dentistry because of its antimicrobial effects and its potential to improve conditions for remineralization. However, evidence regarding its clinical effectiveness as an adjunct to remineralizing agents remains limited.
The aim of this prospective randomized controlled clinical trial is to evaluate the effectiveness of ozone therapy in the management of initial caries lesions in children.
Eligible participants with initial non-cavitated caries lesions will be randomly allocated to one of two study groups. The intervention group will receive ozone therapy followed by application of ROCS Medical Minerals remineralizing gel, while the control group will receive ROCS Medical Minerals remineralizing gel alone.
Participants will be evaluated at baseline and during follow-up visits according to the study protocol. Changes in lesion characteristics and remineralization outcomes will be monitored using clinical and optical assessment methods.
The primary objective of the study is to determine whether adjunctive ozone therapy provides additional benefit in promoting remineralization compared with remineralizing gel alone. The findings may provide further evidence regarding minimally invasive management of early caries lesions in children.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Neslihan Atmaca, Doctor of Dental Surgery
- Phone Number: +905458314053
- Email: nsltmc@gmail.com
Study Locations
-
-
Maltepe
-
Istanbul, Maltepe, Turkey (Türkiye), 34854
- Recruiting
- Marmara Universty School of Dentistry
-
Contact:
- Neslihan Atmaca, Doctor of Dental Surgery
- Phone Number: +905458314053
- Email: nsltmc@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Ozone Group
Participants receive ozone therapy followed by ROCS Medical Minerals gel application for the management of initial caries lesions.
|
Ozone therapy administered using the Ozonytron device for the treatment of initial caries lesions.
ROCS Medical Minerals gel applied according to the manufacturer's instructions for remineralization of initial caries lesions.
|
|
Active Comparator: Control Group
Participants receive ROCS Medical Minerals gel alone for the management of initial caries lesions.
|
ROCS Medical Minerals gel applied according to the manufacturer's instructions for remineralization of initial caries lesions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Quantitative Light-Induced Fluorescence (QLF) fluorescence loss (ΔF) values of initial caries lesions
Time Frame: Baseline, Weeks 1, 2, 3, 4, and Week 8
|
Fluorescence loss (ΔF) values of each initial caries lesion will be assessed using the QrayCam Pro system at baseline and follow-up visits (Weeks 1, 2, 3, 4, and 8).
The outcome will be reported as the change in ΔF values from baseline to each follow-up visit.
Lower ΔF values indicate greater remineralization, reflecting reduced mineral loss.
|
Baseline, Weeks 1, 2, 3, 4, and Week 8
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in DIAGNOdent Pen laser fluorescence values of initial caries lesions
Time Frame: Baseline, Weeks 1, 2, 3, 4, and Week 8
|
Laser fluorescence values of each initial caries lesion will be assessed using the DIAGNOdent Pen at baseline and follow-up visits (Weeks 1, 2, 3, 4, and 8).
The outcome will be reported as the change in DIAGNOdent Pen values from baseline to each follow-up visit.
Lower DIAGNOdent values indicate reduced lesion severity and improved lesion status.
|
Baseline, Weeks 1, 2, 3, 4, and Week 8
|
|
Change in the clinical appearance of initial caries lesions assessed using standardized intraoral photographs
Time Frame: Baseline, Weeks 1, 2, 3, 4, and Week 8
|
The clinical appearance of each initial caries lesion will be assessed using standardized intraoral photographs obtained at baseline and follow-up visits (Weeks 1, 2, 3, 4, and 8).
The outcome will be reported as changes in lesion appearance from baseline to each follow-up visit using predefined clinical evaluation criteria.
|
Baseline, Weeks 1, 2, 3, 4, and Week 8
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MUPEDDENTNSL-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Caries
-
National University of San Marcos, PeruNot yet recruitingPit and Fissure Caries | Caries,Dental | Sealant DentalPeru
-
Ain Shams UniversityCompletedPulpitis | Caries | Caries,Dental | Reversible Pulpitis | Caries Class I | Caries; DentinEgypt
-
University of MinnesotaCompletedUsing Motivational Interviewing To Reduce Parental Risk-Related Behaviors For Early Childhood CariesCaries | Caries,DentalUnited States
-
Future University in EgyptNot yet recruitingDeep Caries | Caries, Dental
-
Federal University of PelotasRecruiting
-
Kompetansesenteret Tannhelse Midt (TkMidt)Karolinska Institutet; University of Bergen; Norwegian University of Science... and other collaboratorsActive, not recruiting
-
Marmara UniversityCompleted
-
Suez Canal UniversityCompleted
-
Pomeranian Medical University SzczecinCompleted
-
Rawda Hesham Abd ElAzizRecruitingCaries,Dental | Caries Class IIEgypt
Clinical Trials on Ozone Therapy
-
Asmat BurhanCompletedDiabetic Foot Ulcer | Wound Heal | OzoneIndonesia
-
Anhembi Morumbi UniversityActive, not recruitingBladder Pain Syndrome | Interstitial Cystitis, ChronicBrazil
-
Bernardino Clavo, MD, PhDDr. Negrin University Hospital; Council of Gran Canaria; Fundacion Canaria Instituto... and other collaboratorsNot yet recruitingChronic Pain | Chemotherapy-Induced Peripheral Neuropathy | Radiation Toxicity | Delayed Wound Healing | Refractory SymptomsSpain
-
Pamukkale UniversityCompletedSystemic SclerosisTurkey
-
Bernardino Clavo, MD, PhDServicio Canario de Salud; Red de Investigación en Servicios de Salud en Enfermedades... and other collaboratorsRecruitingChronic Pain | Radiation Toxicity | Chemotherapeutic Toxicity | Chemotherapy-induced Peripheral Neuropathy | Refractory Pain | Delayed Wound HealingSpain
-
Ankara Etlik City HospitalCompletedPain | Activities of Daily Living | Lipedema | Musculoskeletal UltrasoundTurkey (Türkiye)
-
Istanbul UniversityCompleted
-
Pamukkale UniversityCompleted
-
University of BrasiliaNot yet recruitingXerostomia Following Radiotherapy
-
Firat UniversityRecruiting